The largest database of trusted experimental protocols

Amoxicillin

Manufactured by GlaxoSmithKline
Sourced in Spain

Amoxicillin is a broad-spectrum antibiotic medication used to treat a variety of bacterial infections. It is a semi-synthetic derivative of penicillin and functions by inhibiting the synthesis of bacterial cell walls, leading to cell death. Amoxicillin is available in various dosage forms and can be administered orally.

Automatically generated - may contain errors

6 protocols using amoxicillin

1

Dental Implant Surgical Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were treated by the same surgeon (A-P, R). The implants used in the trial were Vega Klockner implants (Escaldes-Engordany, Andorra) with internal hexagonal connection associated with conical geometry. These implants are fabricated from grade IV titanium with two-stage surface treatment (alumina sandblasting and thermochemical treatment). All implants were placed following the same surgical protocol: implants were placed at bone crest level in nongrafted mature bone using full-thickness surgical flap without releasing, making a supracrestal intrasulcular incision from the adjacent teeth (Figure 3).
After surgery, 1 g Amoxicillin was administered (GlaxoSmithKline, Madrid, Spain), or Clindamycin 300 mg in case of allergy, one every 8 h for 7 days; and 600 mg ibuprofen (Bexistar, Laboratorio Bacino, Barcelona, Spain) as postoperative medication. As coadjuvant treatment, 0.12% Chlorhexidine mouthwash was prescribed (GUM, John O. Butler/Sunstar, Chicago, IL, USA) three times per day.
After surgery, patients returned for check-ups one week, one month, and three months later, when prosthetic loading was performed.
+ Open protocol
+ Expand
2

Postoperative Antibiotic and Oral Care Regimen

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patients were given antibiotics (875 mg amoxicillin and 125 mg clavulanic acid) (1000 mg tablets; GlaxoSmithKline, Istanbul, Turkey) twice a day for seven days, analgesics (550 mg naproxen sodium; Bilim Ilac, Istanbul, Turkey) twice a day for seven days, mouthwash (CHX digluconate rinses; 0.12%; Drogsan, Ankara, Turkey) twice a day for four weeks, and provided with a diet program [33] . Patients were informed that the drugs and mouthwashes should be taken at the appropriate dose and time intervals and were reminded to follow their oral hygiene instructions. Sutures were removed two weeks after surgery. The patients were examined two, four, six, twelve weeks, and nine months after surgery. Maintenance appointments were scheduled every month for the duration of the study for clinical evaluations and to reinforce oral hygiene instructions. Professional maintenance (gentle supragingival debridement) was performed at follow-up appointments-if necessary. Neither probing nor subgingival instrumentation was used until nine months after surgery. Surgical procedures were completed within two months. There were no cases of infection or other adverse complications at any treatment site throughout the study.
+ Open protocol
+ Expand
3

Prophylactic Antibiotic Regimen for TMJ

Check if the same lab product or an alternative is used in the 5 most similar protocols
Augmentin 1-g tablets (equivalent to Amoxicillin 875 mg and clavulanic acid 125 mg, Glaxo SmithKline Pharmaceuticals Ltd., USA) twice daily for 6 days to prevent any chance of TMJ infection.
+ Open protocol
+ Expand
4

Chemical Reagents for Analytical Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemicals used in the present work were purchased from various companies. Sodium nitrite, potassium persulfate, dipotassium hydrogenphosphate, ferric chloride, monosodium dihydrogenphosphate, potassium ferricyanide, trichloroacetic acid, disodium hydrogenphosphate, Rutin, Mueller-Hinton agar (MHA), and Folin-Ciocalteu reagent were purchased from Merck (Darmstadt, Germany), gallic acid from Riedel-de-Haen (Seelze, Germany), ammonium molybdate, linoleic acid, ferrous chloride tetrahydrate and aluminum chloride from BDH Labs (Cambridge, England), DPPH (2,2-diphenyl-1-picrylhydrazyl) and ascorbic acid from MP Biomedicals (Illkirch, France), sodium acetate from Daejung (Siheung City, Korea), ammonium thiocyanate from Alfa-Aesar (Karlsruhe, Germany), amoxicillin from GlaxoSmithKline (Karachi, Pakistan) and trichloroacetic acid, TPTZ (2,4,6 tripyridyl-s-triazine), ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) were purchased from Sigma-Aldrich (Steinheim, Germany).
+ Open protocol
+ Expand
5

Amoxicillin Reactivity and Protein Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amoxicillin was from Glaxo Smithkline Beecham (Madrid, Spain). Deuterium oxide for NMR studies (D2O) was from Panreac Química SAU (Barcelona, Spain). Potassium phosphate buffer (PBS) for 1H-NMR reactivity studies was prepared in 99.8% D2O at pH 7.4. HRP-Streptavidin and ECL system were from GE Healthcare. Alexa-488 streptavidin was from Molecular Probes. Albumin from human serum, phorbol myristate acetate, iodoacetamide and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) were from Sigma. Biotin-NHS ester was from Aldrich.
+ Open protocol
+ Expand
6

Population PK Study of Intravenous Amoxicillin-Clavulanic Acid in ICU Dogs

Check if the same lab product or an alternative is used in the 5 most similar protocols
This prospective population PK study involving client-owned dogs was carried out at a University teaching hospital. Dogs hospitalized in the intensive care unit (ICU) with prescribed IV AMC acid (Augmentin® 1.2 g for reconstitution as an IV injection or infusion: 1 g of amoxicillin as amoxicillin sodium and 200 mg of clavulanic acid as potassium clavulanate; GlaxoSmithKline UK, Brentford, UK) and with a sampling line placed, such as a long stay or central venous catheter, placed for clinical reasons only, were eligible for the study. Dogs that had already received IV AMC prior to study enrolment were eligible for inclusion, as long as previous doses and administration times were exactly known. Exclusion criteria were dogs with body weight of <10 kg, packed cell volume of <20%, and previous oral or subcutaneous administration of AMC within the previous 2 and 7 days respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!